Trial intelligence / Profile preview

INC280 in Advanced Hepatocellular Carcinoma With c-MET Dysregulation

CTR20140315Phase 2Completed

Sponsor

Novartis

Start

Apr 2014

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1